Publicaciones en colaboración con investigadores/as de David Geffen School of Medicine at UCLA (9)

2026

  1. DB-OTO Gene Therapy for Inherited Deafness

    The New England journal of medicine, Vol. 394, Núm. 11, pp. 1074-1083

2024

  1. Natural History and Surgical Outcomes of Lamellar Macular Holes

    Ophthalmology Retina, Vol. 8, Núm. 3, pp. 210-222

2023

  1. Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis

    Clinical Oncology, Vol. 35, Núm. 12, pp. e676-e688

  2. Gene expression in African Americans, Puerto Ricans and Mexican Americans reveals ancestry-specific patterns of genetic architecture

    Nature Genetics, Vol. 55, Núm. 6, pp. 952-963

  3. Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation

    Ophthalmology and Therapy, Vol. 12, Núm. 1, pp. 401-429

  4. Multi-omic approach associates blood methylome with bronchodilator drug response in pediatric asthma

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 6, pp. 1503-1512

  5. Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy

    Brain : a journal of neurology, Vol. 146, Núm. 4, pp. 1328-1341

  6. Safety of Lenadogene Nolparvovec Gene Therapy Over 5 Years in 189 Patients With Leber Hereditary Optic Neuropathy

    American Journal of Ophthalmology, Vol. 249, pp. 108-125

2022

  1. Study design and baseline characteristics for the reflect gene therapy trial ofm.11778g>A/ ND4-LHON

    BMJ Open Ophthalmology, Vol. 7, Núm. 1